Jeffrey S. Heier

Insider Reports History

Location
Bedford, MA
Signature
/s/ Todd Anderman, Attorney-in-Fact for Jeffrey S. Heier
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey S. Heier:

Stock Role Class Num Shares Value Price $ Report Date Ownership
OCULAR THERAPEUTIX, INC Chief Scientific Officer Common Stock 246K $2.96M $12.04 24 Nov 2025 Direct

Insider Reports Filed by Jeffrey S. Heier

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OCUL OCULAR THERAPEUTIX, INC 24 Nov 2025 1 -$41.8K 4 Chief Scientific Officer 26 Nov 2025, 16:01
OCUL OCULAR THERAPEUTIX, INC 02 Oct 2025 1 -$116K 4 Chief Scientific Officer 06 Oct 2025, 17:10
OCUL OCULAR THERAPEUTIX, INC 25 Aug 2025 1 -$36.9K 4 Chief Scientific Officer 27 Aug 2025, 18:42
OCUL OCULAR THERAPEUTIX, INC 23 May 2025 1 -$21.7K 4 Chief Scientific Officer 27 May 2025, 17:39
OCUL OCULAR THERAPEUTIX, INC 24 Feb 2025 1 -$21K 4 Chief Scientific Officer 26 Feb 2025, 18:25
OCUL OCULAR THERAPEUTIX, INC 25 Nov 2024 1 -$26.6K 4 Chief Scientific Officer 27 Nov 2024, 07:52
OCUL OCULAR THERAPEUTIX, INC 02 Oct 2024 2 $0 4 Chief Scientific Officer 04 Oct 2024, 17:20
OCUL OCULAR THERAPEUTIX, INC 02 Oct 2024 0 $0 3 Chief Scientific Officer 04 Oct 2024, 17:17
OCUL OCULAR THERAPEUTIX, INC 02 Aug 2023 1 $0 4 Director 18 Aug 2023, 21:45
OCUL OCULAR THERAPEUTIX, INC 14 Jun 2023 2 $0 4 Director 16 Jun 2023, 19:02
OCUL OCULAR THERAPEUTIX, INC 17 Oct 2022 1 $0 4 Director 18 Oct 2022, 17:12
OCUL OCULAR THERAPEUTIX, INC 16 Jun 2022 2 $0 4 Director 21 Jun 2022, 20:05
OCUL OCULAR THERAPEUTIX, INC 12 May 2022 1 $45.8K 4 Director 16 May 2022, 16:10
OCUL OCULAR THERAPEUTIX, INC 18 Jun 2021 1 $0 4 Director 22 Jun 2021, 20:00